BU-NOT-SET

CONTACT US
De-risking complex generic OSD development
  • Development
  • Drug product
woman in lab
Case study
Science-led OSD development
  • Development
  • Drug product
lady in lab with PPE
Insight
Advanced deformulation for complex generic development
  • Drug product
  • Manufacturing
three scientists in laboratory
White paper
How to turn development challenges into predictable outcomes
  • Development
  • Drug product
two scientists in laboratory
Webinar
Managing risk as high-potency manufacturing scales
  • Drug product
white powder
Insight
Safely scaling high potency API manufacturing
  • Drug product
api white powder
Insight
A predictive approach to complex OSD development
  • Development
  • Drug product
OSD development
eBook
Predictable development for uneventful manufacturing
  • Development
Development Services Recipharm
Video
Building Better RNA Medicines Through Smarter LNP Formulation
  • Biologics
  • Drug product
mRNA image
Insight
Insight
  • Industry trends
Key trends in pharmaceutical outsourcing
Insight
  • Drug product
  • Industry trends
The latest trends and innovations in oral drug delivery
Insight
  • Corporate
Recipharm invests in African vaccine production
Insight
  • Drug product
  • Industry trends
The future of oral solid dose development and manufacturing
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine
Insight
  • Drug product
Three trends driving small molecule API market growth
Fact sheet
  • Drug product
Vaccine manufacturing
Insight
  • Drug product
Solving the challenges during oral solid dosage development